Cargando…

Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression

BACKGROUND: Hepatocellular carcinoma (HCC) with stemness features are pivotal for tumorigenesis, chemoresistance, and progression. Long non-coding RNAs have been implicated in the regulation of HCC stemness features; however, their mechanisms remain largely unknown. Here, we found that Lnc-PDZD7 is...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Tang, Bo, Song, Jun, Yu, Shuiping, Li, Yang, Su, Huizhao, He, Songqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381703/
https://www.ncbi.nlm.nih.gov/pubmed/30786928
http://dx.doi.org/10.1186/s13046-019-1106-2
_version_ 1783396554657234944
author Zhang, Yi
Tang, Bo
Song, Jun
Yu, Shuiping
Li, Yang
Su, Huizhao
He, Songqing
author_facet Zhang, Yi
Tang, Bo
Song, Jun
Yu, Shuiping
Li, Yang
Su, Huizhao
He, Songqing
author_sort Zhang, Yi
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) with stemness features are pivotal for tumorigenesis, chemoresistance, and progression. Long non-coding RNAs have been implicated in the regulation of HCC stemness features; however, their mechanisms remain largely unknown. Here, we found that Lnc-PDZD7 is a potential oncogene. We systematically analyzed the clinical significance and mechanism of Lnc-PDZD7 in stemness and chemosensitivity regulation. METHODS: We analyzed the Lnc-PDZD7 expression levels in liver cancer tissues and cell line by qRT-PCR and In situ hybridization. Gain- and loss-of-function experiments were conducted to investigate the biological functions of Lnc-PDZD7 in stemness and chemosensitivity regulation. Bioinformatics analysis, dual-luciferase reporter assays were performed to validate that Lnc-PDZD7 competitively regulates EZH2, Moreover, chromatin immunoprecipitation assays, bisulfite genomic sequencing and Western blot were performed to evaluate the mechanisms of EZH2 repressing ATOH8. RESULTS: Lnc-PDZD7 is frequently upregulated in HCC tissues. Patients with high Lnc-PDZD7 expression had poorer prognoses and a poor response to adjuvant TACE therapy. Lnc-PDZD7 could promote stemness features and suppress the sensitivity of HCC cells to anticancer drugs in vitro and in vivo. Mechanistically, Lnc-PDZD7 functioned as a molecular sponge for miR-101, antagonizing its ability to repress EZH2 expression. Subsequently, EZH2 can further inhibit the expression of the stemness regulator ATOH8 via elevating its H3K27 trimethylation and DNA methylation. CONCLUSION: Lnc-PDZD7 promotes stemness properties and suppresses chemosensitivity though the miR-101/EZH2/ATOH8 pathway, providing new biomarkers for diagnosis and potential drug targets for HCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1106-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6381703
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63817032019-03-01 Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression Zhang, Yi Tang, Bo Song, Jun Yu, Shuiping Li, Yang Su, Huizhao He, Songqing J Exp Clin Cancer Res Research BACKGROUND: Hepatocellular carcinoma (HCC) with stemness features are pivotal for tumorigenesis, chemoresistance, and progression. Long non-coding RNAs have been implicated in the regulation of HCC stemness features; however, their mechanisms remain largely unknown. Here, we found that Lnc-PDZD7 is a potential oncogene. We systematically analyzed the clinical significance and mechanism of Lnc-PDZD7 in stemness and chemosensitivity regulation. METHODS: We analyzed the Lnc-PDZD7 expression levels in liver cancer tissues and cell line by qRT-PCR and In situ hybridization. Gain- and loss-of-function experiments were conducted to investigate the biological functions of Lnc-PDZD7 in stemness and chemosensitivity regulation. Bioinformatics analysis, dual-luciferase reporter assays were performed to validate that Lnc-PDZD7 competitively regulates EZH2, Moreover, chromatin immunoprecipitation assays, bisulfite genomic sequencing and Western blot were performed to evaluate the mechanisms of EZH2 repressing ATOH8. RESULTS: Lnc-PDZD7 is frequently upregulated in HCC tissues. Patients with high Lnc-PDZD7 expression had poorer prognoses and a poor response to adjuvant TACE therapy. Lnc-PDZD7 could promote stemness features and suppress the sensitivity of HCC cells to anticancer drugs in vitro and in vivo. Mechanistically, Lnc-PDZD7 functioned as a molecular sponge for miR-101, antagonizing its ability to repress EZH2 expression. Subsequently, EZH2 can further inhibit the expression of the stemness regulator ATOH8 via elevating its H3K27 trimethylation and DNA methylation. CONCLUSION: Lnc-PDZD7 promotes stemness properties and suppresses chemosensitivity though the miR-101/EZH2/ATOH8 pathway, providing new biomarkers for diagnosis and potential drug targets for HCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1106-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-20 /pmc/articles/PMC6381703/ /pubmed/30786928 http://dx.doi.org/10.1186/s13046-019-1106-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Yi
Tang, Bo
Song, Jun
Yu, Shuiping
Li, Yang
Su, Huizhao
He, Songqing
Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
title Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
title_full Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
title_fullStr Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
title_full_unstemmed Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
title_short Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
title_sort lnc-pdzd7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through ezh2-mediated atoh8 transcriptional repression
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381703/
https://www.ncbi.nlm.nih.gov/pubmed/30786928
http://dx.doi.org/10.1186/s13046-019-1106-2
work_keys_str_mv AT zhangyi lncpdzd7contributestostemnesspropertiesandchemosensitivityinhepatocellularcarcinomathroughezh2mediatedatoh8transcriptionalrepression
AT tangbo lncpdzd7contributestostemnesspropertiesandchemosensitivityinhepatocellularcarcinomathroughezh2mediatedatoh8transcriptionalrepression
AT songjun lncpdzd7contributestostemnesspropertiesandchemosensitivityinhepatocellularcarcinomathroughezh2mediatedatoh8transcriptionalrepression
AT yushuiping lncpdzd7contributestostemnesspropertiesandchemosensitivityinhepatocellularcarcinomathroughezh2mediatedatoh8transcriptionalrepression
AT liyang lncpdzd7contributestostemnesspropertiesandchemosensitivityinhepatocellularcarcinomathroughezh2mediatedatoh8transcriptionalrepression
AT suhuizhao lncpdzd7contributestostemnesspropertiesandchemosensitivityinhepatocellularcarcinomathroughezh2mediatedatoh8transcriptionalrepression
AT hesongqing lncpdzd7contributestostemnesspropertiesandchemosensitivityinhepatocellularcarcinomathroughezh2mediatedatoh8transcriptionalrepression